Richard Arakaki
Endocrinology, Diabetes & Metabolism · Phoenix, AZNPI 1093702656
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.2%), food and beverage and education — rather than concentrated in one kind of arrangement. Bayer accounts for 60.0% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2021 at $3,382 and has fallen 95.4% since, to $154 in 2025.
Across 73 payments — averaging $78.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$3K
- Viiv Healthcare Company$474
- Novo Nordisk$411
- Tandem Diabetes Care, Inc.$170
- Gilead$169
- AbbVie$162
- plus $902 from 17 others
Across 1 payment — averaging $14,644 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$15K
What the payments were for
- Consulting fees$3,04553%
- Food & beverage$2,61546%
- Education$651%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 8 | $3,437 |
| Viiv Healthcare Company | 13 | $474 |
| Novo Nordisk | 8 | $411 |
| Tandem Diabetes Care, Inc. | 2 | $170 |
| Gilead | 4 | $169 |
| AbbVie | 7 | $162 |
| Boehringer Ingelheim | 6 | $162 |
| Corcept Therapeutics | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Novartis | 4 | $91 |
| Merck | 3 | $54 |
| Janssen Products, LP | 1 | $50 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Indivior Inc. | 2 | $41 |
| Johnson & Johnson(2 entities) | 2 | $37 |
| Lilly USA, LLC | 2 | $32 |
| GSK | 1 | $28 |
| BETA Bionics, Inc. | 1 | $26 |
| Amarin Pharma, Inc. | 1 | $20 |
| VBI Vaccine (delaware) Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
| Organon | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$3,285
- t:slim X2 Insulin Pump with Control-IQ$148
- Korlym$125
- UZEDY$125
How this compares
$5,724 in reported general payments places this provider in the 70th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
See all endocrinology, diabetes & metabolism providers in Arizona →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 29 | $27,684 |
| OzempicSemaglutide | 14 | $24,449 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $32 | $27,68429 claims |
| Novo NordiskOzempic | $411 | $24,44914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
Other endocrinology, diabetes & metabolism in Phoenix
- Kevin YuenPhoenix$404K
- Joan BaileyPhoenix$316K
- Anna BoronPhoenix$32K
- Kari EdlingPhoenix$23K
- James DeerPhoenix$13K
- Lory BarazPhoenix$10K
- Sathya JyothinagaramPhoenix$10K
- Philip LevyPhoenix$9K
- Yasmin AkhunjiPhoenix$5K
- Ahmad Al MaradniPhoenix$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.